Screener / SEC EDGAR /CIK 0001237831 /10-K filed Feb 24, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Medical Instruments

Globus Medical Inc GMED

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 13 Form 144 notices for $18.8M

10-Q, 10-K and Form 144
Plans running now 5 Kyle R. Kline, Ann D. Rhoads, Berachah Foundation, David D. Davidar, Kelly G. Huller
Plans adopted 17 reported since May 4, 2023 Form 144 notices 13 $18.8M the sellers expected to sell

What GMED's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Dec 4, 2024 to Nov 30, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Kyle R. Kline
Chief Financial Officer and Senior Vice President
Adopted 10b5-1 plan Aug 31, 2026 10-Q Nov 5, 2026
What the company wrote
On August 31, 2026, Kyle R. Kline, Chief Financial Officer and Senior Vice President, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Kline’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) November 30, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 25,493 shares of Class A Common pursuant to the terms of the plan.
Ann D. Rhoads
a member of the Board
Adopted 10b5-1 plan Jun 10, 2026 10-Q Aug 6, 2026
What the company wrote
On June 10, 2026, Ann D. Rhoads, a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Ms. Rhoads’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) September 10, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 25,000 shares of Class A Common pursuant to the terms of the plan.
Keith W. Pfeil
Chief Executive Officer and President
Ended 10b5-1 plan Feb 27, 2026 10-Q May 7, 2026
What the company wrote
On March 13, 2026, Keith W. Pfeil, the Company’s Chief Executive Officer and President, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Pfeil’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) June 12, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 90,000 shares of Class A Common pursuant to the terms of the plan.
Berachah Foundation
member of the Board
Adopted 10b5-1 plan Dec 10, 2025 10-K Feb 24, 2026
What the company wrote
On December 10, 2025, Berachah Foundation (David D. Davidar's Foundation), a foundation of a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. The foundation’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) December 31, 2026 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 9,100 shares of Class A Common pursuant to the terms of the plan.
David D. Davidar
member of the Board
Adopted 10b5-1 plan Dec 10, 2025 10-K Feb 24, 2026
What the company wrote
On December 10, 2025, David D. Davidar, a member of the Board, adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Mr. Davidar’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) December 31, 2026 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 36,000 shares of Class A Common pursuant to the terms of the plan.
Kelly G. Huller
Executive Vice President and General Counsel
Adopted 10b5-1 plan Nov 12, 2025 10-K Feb 24, 2026
What the company wrote
On November 12, 2025, Kelly G. Huller, the Company's Executive Vice President and General Counsel, adopted a trading plan intended to satisfy the condition under Rule 10b5-1(c) of the Exchange Act. Ms. Huller’s Rule 10b5-1 trading plan has a term ending upon the earlier of (i) February 7, 2027 or (ii) the sale of all shares subject to the plan and provides for the sale of up to 67,500 shares of Class A Common pursuant to the terms of the plan.
Leslie V. Norwalk
Member of the Board of Directors
Adopted 10b5-1 plan Sep 12, 2025 10-Q Nov 6, 2025
Kyle R. Kline
Chief Financial Officer and Senior Vice President
Adopted 10b5-1 plan Aug 25, 2025 10-Q Nov 6, 2025
Daniel T. Scavilla
President and Chief Executive Officer
Ended 10b5-1 plan Aug 12, 2025 10-Q Nov 6, 2025
Keith Pfeil
Executive Vice President, Chief Operating Officer and Chief Financial Officer
Adopted 10b5-1 plan Mar 15, 2025 10-Q May 8, 2025
Daniel T. Scavilla
President and Chief Executive Officer
Adopted 10b5-1 plan Dec 10, 2024 10-K Feb 20, 2025
Kelly Huller
Executive Vice President and General Counsel
Adopted 10b5-1 plan Dec 4, 2024 10-K Feb 20, 2025
Ann D. Rhoads
Director
Adopted 10b5-1 plan Nov 11, 2024 10-K Feb 20, 2025
Kelly G. Huller
Senior Vice President and General Counsel
Adopted 10b5-1 plan Jun 13, 2024 10-Q Aug 6, 2024
Daniel T. Scavilla
President and Chief Executive Officer
Adopted 10b5-1 plan Jun 7, 2024 10-Q Aug 6, 2024
Keith W. Pfeil
Chief Operating Officer and Chief Financial Officer
Adopted 10b5-1 plan Dec 15, 2023 10-K Feb 21, 2024
David D. Davidar
Irrevocable Trust
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 21, 2024
David D. Davidar
Director
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 21, 2024
Leslie V. Norwalk
Director
Adopted 10b5-1 plan Dec 14, 2023 10-K Feb 21, 2024
Show the other 11 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 10, 2026 TOBIN JAMES R
Director
41,666 $3.1M
Nov 4, 2026 RHOADS ANN D
Director
5,000 $425K
Sep 15, 2026 TOBIN JAMES R
Director
30,000 $2.2M
Aug 18, 2026 ZARRILLI STEPHEN T
Director
25,000 $2.2M
Jun 5, 2026 Davidar David D
Director
25,000 $2.0M
Apr 14, 2026 DeFord John A
Former Director
30,000 $2.8M
Feb 25, 2026 Huller Kelly
Officer
20,000 $1.9M
Feb 12, 2026 Huller Kelly
Officer
10,000 $876K
Jan 8, 2026 Kline Kyle
Officer
3,594 $363K
Jan 8, 2026 Norwalk Leslie V
Director
2,000 $202K
Dec 12, 2025 Norwalk Leslie V
Director
4,000 $355K
Dec 1, 2025 Kline Kyle
Officer
18,542 $1.7M
Nov 25, 2025 Huller Kelly
Officer
7,500 $675K
Show the other 5 notices

From the Form 144 XML filed with the SEC, since Nov 25, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/GMED/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.